In Wyeth, Pfizer Sees a Drug Pipeline

Monday, January 26, 2009 - 19:49 in Psychology & Sociology

Pfizer’s planned acquisition of Wyeth is a validation of Wyeth’s decision to reduce its reliance on small-molecule drugs.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net